The safety of RhIG in the prevention of haemolytic disease of the newborn.
Hirose, T G
The safety of RhIG in the prevention of haemolytic disease of the newborn. [electronic resource] - Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology Aug 2007 - 545-57 p. digital
Publication Type: Journal Article; Review
0144-3615
10.1080/01443610701469941 doi
Erythroblastosis, Fetal--drug therapy
Humans
Rh-Hr Blood-Group System--immunology
Rho(D) Immune Globulin--therapeutic use
Treatment Outcome
The safety of RhIG in the prevention of haemolytic disease of the newborn. [electronic resource] - Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology Aug 2007 - 545-57 p. digital
Publication Type: Journal Article; Review
0144-3615
10.1080/01443610701469941 doi
Erythroblastosis, Fetal--drug therapy
Humans
Rh-Hr Blood-Group System--immunology
Rho(D) Immune Globulin--therapeutic use
Treatment Outcome